LINDSEY HERNANDEZ: Open Payments
NPI 1598482861 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 19 payments from 10 companies in 2025. Trend: 2023 $669 · 2024 $559 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Amgen Inc. | 3 | $52 |
| ABBVIE INC. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Lundbeck LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: TRELEGY ELLIPTA, REXULTI, AIRSUPRA, TRINTELLIX, OTEZLA, QULIPTA, BREZTRI, UBRELVY.
Industry payments across LA — which companies pay providers there.
